| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/27/2001 | CN1300742A Polypeptide-kringle protein 8 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300741A Polypeptide-bromo structure domain 9 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300740A Polypeptide-actin 41 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300739A Polypeptide-ribosome 39 protein 9 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300736A Polypeptide-DBH and PAM 20 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300735A Polypeptide-ribosome 59 protein 26 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300734A Polypeptide-beta-transducin 41 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1067722C Adenoviral vectors |
| 06/27/2001 | CN1067705C Protein high molecular dye |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6252139 Generating genetically engineered plants; incubate cells with nucleotide sequence coding cyclin protein, transform cells, propagate cells, isolate plants with amplified root propagation |
| 06/26/2001 | US6252138 Nucleotide sequences coding nematocide; for the production of disease resistant plants |
| 06/26/2001 | US6252137 Soybean homolog of seed-specific transcription activator from Phaseolus vulgaris |
| 06/26/2001 | US6252134 Generating plant with amplified baked goods qualities; transform wheat cell, propagate cell, recover wheat plants |
| 06/26/2001 | US6252132 Mutant mouse containing a knockout mutation in DNA encoding an endogenous alpha 4 subunit of nicotinic acetylcholine receptor |
| 06/26/2001 | US6252131 Transgenic mammal having 5-HT3 transgene overexpression in the CMS |
| 06/26/2001 | US6252130 Production of somatic mosaicism in mammals using a recombinatorial substrate |
| 06/26/2001 | US6252058 Genetically engineered nucleotide sequences; for the evaluation, diagnosis and treatment of tumors defects |
| 06/26/2001 | US6252057 Protein targeting to glycogen |
| 06/26/2001 | US6252056 Membrane protein; for use as diagnostic tools in the treatment of vasospasms |
| 06/26/2001 | US6252052 Antibodies which bind to NY-ESO-1 cancer associated proteins, and hybridomas which produce these antibodies |
| 06/26/2001 | US6252051 ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor |
| 06/26/2001 | US6252050 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
| 06/26/2001 | US6252049 Protein associated wich is used to generate disease resistant plants |
| 06/26/2001 | US6252046 Protein for the treatment of kidney defects |
| 06/26/2001 | US6252045 Human occludin, its uses and enhancement of drug absorption using occludin inhibitors |
| 06/26/2001 | US6252044 Riboflavin synthase polypeptide; for the controlled biosynthesis of riboflavin; for screening bactericides; for prevention of infection |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6252040 Administering polypeptide |
| 06/26/2001 | US6251920 Administering tamoxifen or its structural analogs for prophylaxis and therapy of atherosclerosis, thrombosis, myocardial infarction and stroke |
| 06/26/2001 | US6251873 Antisense compounds to CD14 |
| 06/26/2001 | US6251872 Nucleic acid vaccines for ehrlichia chaffeensis and methods of use |
| 06/26/2001 | US6251871 Administering pharmaceutical composition comprising adenoviral vector comprising promoter functional in eukaryotic cells and nucleic acid encoding p16 and buffer, solvent or diluent to mammal to inhibit tumor growth |
| 06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
| 06/26/2001 | US6251865 Insulin-like growth factor agonist molecules |
| 06/26/2001 | US6251864 Peptides and compounds that bind to a receptor |
| 06/26/2001 | US6251862 Given nucleic acid and amino acid sequences; polypeptides may be cloned into a baculovirus, and used for insect control |
| 06/26/2001 | US6251860 Virus-safe human apotransferrin having at least 90% of the theoretical iron binding capacity of iron-free transferrin, contains less than 3% transferrin dimers and no transferrin polymers, and has an iron saturation less than 5% |
| 06/26/2001 | US6251859 Deepithelialized skin diffusion cell system |
| 06/26/2001 | US6251856 Insulin derivatives of given amino acid sequences including disulfide bonds linking alpha and beta chains, and including lipophilic group such as tetradecanoyl; treating diabetes; soluble at physiological ph |
| 06/26/2001 | US6251853 Pertussis toxin (ptx); beta-3 subunit of human g protein with not more than six wd repeat motifs; for the diagnosis of disorders, such as a disease associated with g protein dysregulation (i.e. hypertension) |
| 06/26/2001 | US6251675 Modifying cell by delivering mutant rev gene having mutation from amino acid position 68 to 90 of the wild-type protein; intracellular immunization |
| 06/26/2001 | US6251671 Culturing mammalian spermatogonial stem cells with bone morphogenetic protein 8 to cause proliferation of the stem cells and survival of spermatocytes |
| 06/26/2001 | US6251668 Amino acid and nucleotide sequences; transformed cells |
| 06/26/2001 | US6251667 Amino acid sequence; controlling gene expression to increase or decrease production of proteins |
| 06/26/2001 | US6251666 Ribozyme with at least one l-nucleotide substitution; nuclease resistance |
| 06/26/2001 | US6251656 Insecticidal protein fragments |
| 06/26/2001 | US6251654 Modified small RNA viruses |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251650 Pseudomonas putida amidase polypeptide useful for the production of chiral amides and acids |
| 06/26/2001 | US6251649 Thermostable flap endonuclease derived from a hyperthermophile bacterium belonging to the genus pyrococcus |
| 06/26/2001 | US6251647 Nucleotide and amino acid sequences; drug screening of bactericides for staphylococcus infections |
| 06/26/2001 | US6251645 Leflunomide-resistant helicase; anticarcinogenic agents; antidiabetic agents; immunosuppressants; treatment of alzheimer's disease, atherosclerosis, osteoporosis, autoimmune disorders, and rheumatoid arthritis |
| 06/26/2001 | US6251644 Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer |
| 06/26/2001 | US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides |
| 06/26/2001 | US6251635 Condensing an n-terminal fragment of defined amino acid sequence with recombinantly-formed polypeptide of defined amino acid sequence in presence of non-enzymatic coupling reagent |
| 06/26/2001 | US6251634 Recombinant dna encoding gp63 glycoprotein of defined amino acid sequence; recombinant culture production; vaccines |
| 06/26/2001 | US6251633 Polynucleotides encoding Staphylococcus aureus FtsA polypeptide |
| 06/26/2001 | US6251632 Nucleotide and amino acid sequences; diagnosis and treatment of blood disorders in dogs |
| 06/26/2001 | US6251631 Nucleotide sequence coding for ammonia dependent nicotinamide-adenine dinucleotide synthetase; probes for detection of infections |
| 06/26/2001 | US6251629 Nucleotide sequence of transport protein from staphylococcus; recombinant culture production; drug screening; bacteriostats; bactericides; probes; primers; vaccines |
| 06/26/2001 | US6251628 Isolated nucleic acid molecules encoding Smad7 |
| 06/26/2001 | US6251627 Antigen presenting system and methods for activation of T-cells |
| 06/26/2001 | US6251617 Screening for modulators of glycine transport; incubate cells with modulator and measure amount of glycine transport activity |
| 06/26/2001 | US6251605 Yeast cells having mutations in Cav1 and uses therefor |
| 06/26/2001 | US6251603 Evaluating cancer in humans; detect preferential gene expression in tumor, mix sample with antibodies which bind preferential protein, count amount of protein, an amplified protein value indicates adjustment in cancer classification |
| 06/26/2001 | US6251602 Cell systems having specific interaction of peptide binding pairs |
| 06/26/2001 | US6251597 Methods for detecting fohy030 |
| 06/26/2001 | US6251586 Epithelial protein and DNA thereof for use in early cancer detection |
| 06/26/2001 | US6251583 Chromogenic hepatitis c virus substrate of a chromaphore such as nitrophenol, 4-phenylazophenol, or 7-hydroxy-4-methylcoumarin linked to c-terminus of a peptide sequence; screening enzyme inhibitors |
| 06/26/2001 | US6251438 Method of preparing active substances from nacre, products obtained which can be used in particular as medicaments |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251406 Attenuated microorganism strains and their uses |
| 06/26/2001 | US6251405 Comprising borrelia burgdorferi outer surface protein (osp)c antigen and a second antigenic lipoprotein such as recombinant ospa, or streptococcus pneumoniae cell surface protein (pspa), both in same physio-chemical form |
| 06/26/2001 | US6251404 Collecting a sample of a naturally occurring isolated virus such as the iowa strain, and a naturally occuring strain that causes lesions in colostrum deprived piglets, treating to deactivate virus and admixing with carrier |
| 06/26/2001 | US6251403 Comprising a foreign dna encoding a cytokine inserted into a swinepox virus genome within a nonessential region and expressed in a host cell into which the virus is introduced; swinepox virus as a vector for delivery of vaccine antigens |
| 06/26/2001 | US6251401 Comprising haemophilus influenzae type b and neisseria meningitidis serotype c capsular oligosaccharide conjugates, where the oligosaccharides are size-selected to exclude short chain oligosaccharides |
| 06/26/2001 | US6251399 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 06/26/2001 | US6251398 Fusion proteins comprising transport proteins comprising sequences from herpesviral vp22 or fragments thereof together with an antigenic sequence greater than 12 amino acids in length |
| 06/26/2001 | US6251397 Purified polypeptides encoded by open reading frames (orf's) of a highly virulent strain of the virus as determined by its ability to induce lung lesions in 51.9% of colostrum-deprived piglets; vaccines |
| 06/26/2001 | US6251396 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 06/26/2001 | US6251395 Inhibiting macrophage infiltration at the site of a central nervous system injury such as spinal cord injury by administering an anti-integrin subunit alpha-d monoclonal antibody |
| 06/26/2001 | US6251390 Purified chitinases and use thereof |
| 06/26/2001 | US6251385 Antigen stimulated cells for cancer treatment, free of bodily fluids |
| 06/26/2001 | US6251384 Metastasis models using green fluorescent protein (GFP) as a marker |
| 06/26/2001 | CA1341263C Recombinant fowlpox virus, heterologous protein expression vectors, and fowl vaccines derived from this virus |
| 06/21/2001 | WO2001044816A2 Conformational and topological protein regulation |
| 06/21/2001 | WO2001044815A1 Helicobacter pylori antigens in blood |
| 06/21/2001 | WO2001044807A1 METHOD OF SCREENING REMEDY FOR CANCER WITH THE USE OF INTERACTION DOMAINS OF p53 AND MORTALIN |
| 06/21/2001 | WO2001044512A2 Method of identifying ligands for the peroxisome proliferator activated receptor gamma using differential gene expression |
| 06/21/2001 | WO2001044497A2 Protein kinase regulation |
| 06/21/2001 | WO2001044490A2 A NOVEL METHOD TO PRODUCE HUMAN NATURAL INTERFERON-$g(a) |
| 06/21/2001 | WO2001044481A1 Fusion protein delivery system and uses thereof |
| 06/21/2001 | WO2001044476A2 Moss genes from physcomitrella patens encoding proteins involved in the synthesis of carbohydrates |
| 06/21/2001 | WO2001044475A1 Novel polypeptide and dna thereof |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044471A1 Ring finger protein zapop2 |
| 06/21/2001 | WO2001044469A1 PROCESS FOR PRODUCING KiSS-1 PEPTIDE |